Literature DB >> 17132978

Cognitive change in Parkinson disease.

James E Galvin1.   

Abstract

Parkinson disease (PD) is the most common neurodegenerative movement disorder, affecting 1 in 100 individuals over the age of 60. Dementia in the setting of PD (PDD) may be among the most debilitating symptoms associated with disease progression. Estimates of cognitive decline and dementia in PD suggest that up to 14% per year of patients over age 65 with PD will develop some cognitive impairment. Unfortunately, PDD is not well characterized and the relationship of PDD to Alzheimer disease remains unclear. PDD has been proposed as part of a spectrum with dementia with Lewy bodies, and PDD and dementia with Lewy bodies frequently coexist with Alzheimer disease. It is uncertain, however, whether there is a meaningful distinction between the different disorders. It has also been difficult to gain understanding of the interaction of motor and non-motor symptoms that affect quality of life in PD and confound cognitive and psychomotor performance. This review will examine the clinical, cognitive, neuropsychiatric features of cognitive deficits associated with PD, discuss their pathologic basis and propose avenues for future research.

Entities:  

Mesh:

Year:  2006        PMID: 17132978     DOI: 10.1097/01.wad.0000213858.27731.f8

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  22 in total

Review 1.  Profile of cognitive impairment in Parkinson's disease.

Authors:  G Stennis Watson; James B Leverenz
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

2.  DEVELOPMENT OF CLINICAL DEMENTIA RATING SCALE CUTOFF SCORES FOR PATIENTS WITH PARKINSON'S DISEASE.

Authors:  Kathryn A Wyman-Chick; B J Scott
Journal:  Mov Disord Clin Pract       Date:  2015-04-20

Review 3.  Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for "mild cognitive impairment" and biomarkers.

Authors:  Alexander I Tröster
Journal:  Neuropsychol Rev       Date:  2008-03-06       Impact factor: 7.444

4.  A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease.

Authors:  Birgit Herting; Susann Schulze; Heinz Reichmann; Antje Haehner; Thomas Hummel
Journal:  J Neurol       Date:  2008-03-19       Impact factor: 4.849

5.  Medical management of Parkinson's disease.

Authors:  Marvin M Goldenberg
Journal:  P T       Date:  2008-10

6.  The relation of anxiety and cognition in Parkinson's disease.

Authors:  Gretchen O Reynolds; Kristine K Hanna; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Neuropsychology       Date:  2017-04-20       Impact factor: 3.295

Review 7.  The spectrum of cognitive impairment in Lewy body diseases.

Authors:  Jennifer G Goldman; Caroline Williams-Gray; Roger A Barker; John E Duda; James E Galvin
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

8.  Onset of Mild Cognitive Impairment in Parkinson Disease.

Authors:  David K Johnson; Zachary Langford; Mauricio Garnier-Villarreal; John C Morris; James E Galvin
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Apr-Jun       Impact factor: 2.703

Review 9.  Population Base Rates and Disease Course of Common Psychiatric and Neurodegenerative Disorders.

Authors:  Katherine A Kitchen Andren; Nicolette M Gabel; Julija Stelmokas; Alyson M Rich; Linas A Bieliauskas
Journal:  Neuropsychol Rev       Date:  2017-09-22       Impact factor: 7.444

10.  Neuropathologic substrates of Parkinson disease dementia.

Authors:  David J Irwin; Matthew T White; Jon B Toledo; Sharon X Xie; John L Robinson; Vivianna Van Deerlin; Virginia M-Y Lee; James B Leverenz; Thomas J Montine; John E Duda; Howard I Hurtig; John Q Trojanowski
Journal:  Ann Neurol       Date:  2012-10-04       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.